Preetam Shah - Chief Financial Officer at Cidara Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Preetam Shah - trading volume in the past year for Cidara Therapeutics, Inc.

Holdings reported by Preetam Shah for Cidara Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 336K $232K $0.69 Mar 15, 2024 Direct
Employee Stock Option (right to buy) 218K Mar 15, 2024 Direct Common Stock
Employee Stock Option (right to buy) 130K Sep 30, 2024 Direct Common Stock

Transactions reported by Preetam Shah for Cidara Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.